NIH Experimental Ebola Vaccine Trial Begins; Other Vaccines, Treatments Under Development
News outlets report on various aspects of Ebola vaccine and treatment development and delivery.
ABC News: Two Women Receive Experimental Ebola Vaccine in Fast-Tracked Trial
“The first two doses of an experimental Ebola vaccine have been injected into human subjects in the National Institutes of Health’s fast-tracked clinical trial…” (Lupkin, 9/3).
Associated Press: Could the blood of Ebola survivors help patients?
“As West Africa struggles to contain the biggest ever outbreak of Ebola, some experts say an unusual but simple treatment might help: the blood of survivors. The evidence is mixed for using infection-fighting antibodies from survivors’ blood for Ebola, but without any licensed drugs or vaccines for the deadly disease, some say it’s worth a shot…” (Cheng, 9/4).
Reuters: J&J Ebola vaccine to start clinical trials in early 2015
“Scientists will fast-track tests on another Ebola vaccine, this time from Johnson & Johnson, in another sign that the world’s worst outbreak of the virus is mobilizing research into the deadly disease…” (Hirschler, 9/4).
Reuters: Canada Ebola vaccine shipment to Africa stymied by logistics
“Canada’s experimental Ebola vaccine was stuck in the government lab that developed it as officials puzzled over how to safely transport it, three weeks after it was offered to Africa to fight the deadly epidemic…” (Nickel, 9/3).
Wall Street Journal: Johnson & Johnson to Quicken Development of Ebola Virus Vaccine
“Johnson & Johnson said Thursday it is accelerating the development of a vaccine regimen against Ebola, in an effort to help curb the virus that has overwhelmed West Africa…” (McCarthy, 9/4).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.